Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 8-K Event Material agreement · Other events
  2. 144 Insider Sale of Securities
  3. 424B5 Offering Prospectus
  4. 8-K Event Regulation FD disclosure · Other events
  5. 4 Planned sale Chief Scientific Officer sold 2,705 shares at an average $28.27 ($76,469)
  6. 4 Planned sale Chief Medical Officer sold 2,381 shares at an average $28.27 ($67,310)
  7. 4 Planned sale Chief Operating Officer sold 2,738 shares at an average $28.27 ($77,402)
  8. 4 Planned sale SVP, Head of Finance & Admin. sold 2,588 shares at an average $28.27 ($73,162)
  9. 4 Planned sale Chief Business Officer sold 2,774 shares at an average $28.27 ($78,420)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 8-K Event Results of operations
  17. 10-Q Report Quarterly Report
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 21 of 40 · 796 filings